TritonPoint Partners’s Medtronic MDT Stock Holding History

TritonPoint Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$368K	Buy	4,685 +2,268	+94%	+$183K	0.03%	259
2026 Q1	$211K	Buy	+2,417	New	+$232K	0.08%	191

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

TritonPoint Partners's MDT Position: Q2 2026 in Review

TritonPoint Partners increased its Medtronic (MDT) stake by 94% in Q2 2026, buying an estimated $183K and bringing the position to 4,685 shares worth $368K. The position accounts for 0.03% of the portfolio, ranked #259.

TritonPoint Partners first reported a position in MDT in Q1 2026 and has held it in 2 quarters since. 2,132 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

TritonPoint Partners held 4,685 shares of Medtronic worth $368K as of Q2 2026.
TritonPoint Partners bought 2,268 Medtronic shares in Q2 2026, an estimated $183K.
Medtronic made up 0.03% of TritonPoint Partners's portfolio in Q2 2026, its #259 holding.
TritonPoint Partners first reported a position in Medtronic in Q1 2026 and has held it in 2 quarters since.
2,132 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on TritonPoint Partners's 13F filing for Q2 2026, filed 13 Aug 2026.